USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities
02-Sep-2015
Asia Pacific
Market Research
MB53-01-00-00-00
LS00110-AP-MR_16951
The study covers provides an assessment of the marketed and pipeline products for the global human albumin market. Segmentation by application has been provided along with additional information such as clinical trial timelines and results, and historical and projected launch timelines. The marketed and pipeline products have been broadly segmented into those used in replacement therapy (fluid-volume replacement therapy), in drug formulation and delivery, as stabilisers for vaccines, and as excipients in imaging and in-vitro fertilisation products. The market shares of the key companies operating in this space have also been listed.
Executive Summary—Key Findings
Executive Summary—Key Findings (continued)
Key Trends
Key Companies to Watch
Methodology and Scope
Market Overview—Introduction
Market Overview—Blood Plasma Production
Blood Plasma Market Share
Demand Analysis of Blood Plasma Proteins
Human Albumin Production
Market Forecast—Human Albumin
Market Forecast—Human Albumin Discussion
Supply Chain and Distribution Network
Supply Chain and Distribution Network (continued)
Porter’s 5 Forces Analysis
Porter’s 5 Forces Analysis (continued)
Porter’s 5 Forces Analysis (continued)
Human Albumin Market Share Analysis
Market Segmentation
Recommendations for Data Center Operators
Competitive Landscape—Marketed and Pipeline Products
Marketed Products—Replacement Therapy
Marketed Products—Replacement Therapy (continued)
Pipeline Products—Replacement Therapy
Marketed Products—Drug Formulation and Delivery
Marketed Products—Drug Formulation and Delivery (continued)
Pipeline Products—Drug Formulation and Delivery
Marketed Products—Vaccine
Pipeline Products—Vaccine
Marketed Products—Others
Total Human Albumin Market—Major Ongoing/Recently Completed Clinical Trials
Summary of Key Products to Watch
Timeline of Key Events—Launch of Products
Product Dashboard: Albuminar—CSL Behring
Product Dashboard: Albutein—Grifols
Product Dashboard: Abraxane—Celgene
Product Dashboard: Victoza—Novo Nordisk
Product Dashboard: Recombumin—Novozymes
Product Dashboard: rIX-FP—CSL Behring
Conclusions
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Sriram Radhakrishnan |
| WIP Number | MB53-01-00-00-00 |
| Keyword 1 | Human albumin |
| Keyword 2 | albumin |
| Is Prebook | No |
Analysis of the Global Human Albumin Market and Product Pipeline
$4,950.00
Special Price $3,712.50 save 25 %